Rodger Novak
CIK 1682017 · President · last filed 2021-07-01
Rodger Novak is a President who has filed 31 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $4.1M of CRSP on Jul 1, 2021. Across all open-market trades the lifetime net is −$65.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.54M
2
31
-$65.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRSP | President | 573,007 | $49.80 | $28.54M | -$60.72M | 19 | 2021-07-01 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Executive Officer | 1,148,007 | — | — | -$5.20M | 12 | 2017-09-05 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-01 | CRSP | Sell (S) | −25,000 | -$4.12M | EDGAR |
| 2021-06-30 | CRSP | Sell (S) | −25,000 | -$3.91M | EDGAR |
| 2021-06-23 | CRSP | Sell (S) | −25,000 | -$3.22M | EDGAR |
| 2020-12-02 | CRSP | Mixed | +50,000 | -$4.83M | EDGAR |
| 2020-10-13 | CRSP | Mixed | — | -$2.14M | EDGAR |
| 2020-09-03 | CRSP | Mixed | — | -$1.96M | EDGAR |
| 2020-08-21 | CRSP | Mixed | — | -$2.15M | EDGAR |
| 2020-07-09 | CRSP | Mixed | — | -$1.97M | EDGAR |
| 2020-07-06 | CRSP | Sell (S) | −50,000 | -$4.00M | EDGAR |
| 2020-06-25 | CRSP | Sell (S) | −50,000 | -$3.75M | EDGAR |